Metis Precision Medicine Companies
Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested in acquiring the relevant platform technology on a global basis.
Founded Date:
2017
Industry:
Advanced and Next Generation Therapies (Various)
Headquarters:
Turin, Piemonte, Italy
Technology:
Healthcare Innovations
Employee Number:
1-10